{
  "id": 5689,
  "url": "https://nnemf.org/research/5689-up-regulation-of-mir-144-and-mir-375",
  "title": "Up-regulation of miR-144 and miR-375 in the human gastric cancer cell line following the exposure to extremely low-frequency electromagnetic fields.",
  "authors": [
    "Fatemeh Aalami Zavareh",
    "Soheila Abdi",
    "Maliheh Entezari"
  ],
  "journal": "International journal of radiation biology",
  "year": "2021",
  "doi": "10.1080/09553002.2021.1941376",
  "pmid": "34125651",
  "abstract": "PURPOSE: Recently, therapeutic effects of extremely low-frequency electromagnetic field (ELF-EMF) as complementary and alternative medicine, used in the oncology field to control disease symptoms. Micro RNAs (miRs) are responsible for the post-transcriptional regulation of gene expression in the cell. This study aimed to evaluate the expression changes of miR-144 and miR-375 in the human gastric adenocarcinoma cell line (AGS) under the exposure of ELF-EMF. MATERIALS AND METHODS: AGS cells were exposed to magnetic flux densities of 0.2 and 2 mT for 18 h, continuously and discontinuously (1.5 h on/1.5 h off). Cell viability was evaluated by MTT assay. Changes of miR-144 expression levels in AGS cells immediately after exposure and 18 and 36 h after the exposure cut-off was calculated by QRT-PCR. RESULTS: The cell viability of AGS cells was decreased under the exposure of 0.2 and 2 mT EMFs when compared to the control. Up-regulation of miR-144 and miR-375 were observed in AGS cells under the exposure of magnetic fields. CONCLUSIONS: The results indicated that the miR levels were significantly decreased 18 and 36 h after finishing the exposure, but not reached the normal range. The results of this investigation indicated that weak and moderate intermittent 50 Hz ELF-EMFs can induce changes in miRNA expression.",
  "effect": "mixed",
  "evidence": "low",
  "extraction": {
    "studyType": "in_vitro",
    "studyTypeLabel": "In vitro study",
    "effectDirection": "mixed",
    "evidenceLabel": "Low",
    "population": "Human gastric adenocarcinoma cell line (AGS)",
    "sampleSize": "—",
    "exposure": "ELF · 0.05 MHz · 18 h (continuous or intermittent 1.5 h on/1.5 h off)",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "AGS cell viability decreased after exposure to 0.2 or 2 mT ELF-EMF compared with control. miR-144 and miR-375 were up-regulated under magnetic field exposure; miR levels were reported to be significantly decreased at 18 and 36 h after exposure ended, but not back to the normal range.",
    "outcomes": [
      "Cell viability (MTT assay)",
      "miR-144 expression (qRT-PCR)",
      "miR-375 expression"
    ],
    "limitations": [
      "In vitro cell-line study",
      "findings may not generalize to humans or clinical outcomes",
      "Sample size not reported in abstract",
      "Exposure source/setup details beyond flux density and frequency not provided in abstract",
      "Only two miRNAs assessed",
      "limited scope of molecular endpoints"
    ],
    "keywords": [
      "ELF-EMF",
      "50 Hz",
      "magnetic field",
      "0.2 mT",
      "2 mT",
      "AGS",
      "gastric adenocarcinoma",
      "cell viability",
      "MTT",
      "miR-144",
      "miR-375",
      "miRNA expression",
      "intermittent exposure"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"in_vitro\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": null,\n    \"frequency_mhz\": 0.05,\n    \"sar_wkg\": null,\n    \"duration\": \"18 h (continuous or intermittent 1.5 h on/1.5 h off)\"\n  },\n  \"population\": \"Human gastric adenocarcinoma cell line (AGS)\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Cell viability (MTT assay)\",\n    \"miR-144 expression (qRT-PCR)\",\n    \"miR-375 expression\"\n  ],\n  \"main_findings\": \"AGS cell viability decreased after exposure to 0.2 or 2 mT ELF-EMF compared with control. miR-144 and miR-375 were up-regulated under magnetic field exposure; miR levels were reported to be significantly decreased at 18 and 36 h after exposure ended, but not back to the normal range.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"In vitro cell-line study; findings may not generalize to humans or clinical outcomes\",\n    \"Sample size not reported in abstract\",\n    \"Exposure source/setup details beyond flux density and frequency not provided in abstract\",\n    \"Only two miRNAs assessed; limited scope of molecular endpoints\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"ELF-EMF\",\n    \"50 Hz\",\n    \"magnetic field\",\n    \"0.2 mT\",\n    \"2 mT\",\n    \"AGS\",\n    \"gastric adenocarcinoma\",\n    \"cell viability\",\n    \"MTT\",\n    \"miR-144\",\n    \"miR-375\",\n    \"miRNA expression\",\n    \"intermittent exposure\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"elf-emf\",\n      \"weight\": 0.9,\n      \"reason\": \"Study evaluates 50 Hz extremely low-frequency electromagnetic fields in vitro.\"\n    },\n    {\n      \"slug\": \"cancer-research\",\n      \"weight\": 0.55,\n      \"reason\": \"Uses a human gastric cancer cell line and assesses viability and miRNA expression changes.\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/34125651/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=5689",
  "updated": "2026-02-14 08:50:33"
}